Avalyn Pharma Inc(AVLN)
$31.17+1.67 (+6.93%)
AVLN
Avalyn Pharma Inc hedge funds
$31.17
At close:+1.67 (+6.93%)
Avalyn Pharma Inc (AVLN) Hedge Fund Trading Activity
8 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 0 Shares Last Quarter
Hedge Fund Holdings in AVLN
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
 Joseph Edelman | Perceptive Advisors LLC | New | 100.00% | $88,070,744 | 1.32% | ||
 BlackRock, Inc. | New | 100.00% | $32,171,531 | <0.01% | |||
 James E. Flynn | Deerfield Management Company, LP | New | 100.00% | $24,064,520 | 0.25% | ||
| Felix Baker | Baker Bros Advisors LP | New | 100.00% | $11,522,000 | 0.06% | ||
| Michael Rockefeller | Woodline Partners LP | New | 100.00% | $4,970,887 | 0.02% | ||
 Louis Moore Bacon | Moore Capital Management LP | New | 100.00% | $3,636,047 | 0.05% | ||
 Stephen A. Schwarzman | Blackstone Inc. | New | 100.00% | $3,225,666 | <0.01% | ||
 George Soros | Soros Fund Mangment LLC | New | 100.00% | $329,200 | <0.01% |
FAQ
Which hedge funds hold Avalyn Pharma Inc?
The hedge funds that hold the most shares in Avalyn Pharma Inc are BlackRock, Inc., Felix Baker and James E. Flynn.
Are hedge funds buying or selling AVLN?
In the last quarter hedge funds have Increased their holdings in Avalyn Pharma Inc by 0 shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Avalyn Pharma Inc stock?
Warren Buffet currently does not own shares in Avalyn Pharma Inc.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
